AR052744A1 - Composiciones que comprenden componentes probioticos y edulcorantes - Google Patents

Composiciones que comprenden componentes probioticos y edulcorantes

Info

Publication number
AR052744A1
AR052744A1 ARP060101416A ARP060101416A AR052744A1 AR 052744 A1 AR052744 A1 AR 052744A1 AR P060101416 A ARP060101416 A AR P060101416A AR P060101416 A ARP060101416 A AR P060101416A AR 052744 A1 AR052744 A1 AR 052744A1
Authority
AR
Argentina
Prior art keywords
composition
edulcorant
compositions
components
probiotic
Prior art date
Application number
ARP060101416A
Other languages
English (en)
Inventor
Marko Stojanovic
Original Assignee
Iams Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Company filed Critical Iams Company
Publication of AR052744A1 publication Critical patent/AR052744A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Una composicion que comprende (a) un componente probiotico; y (b) un componente edulcorante; en donde la composicion prácticamente carece de una base de goma de mascar. Dicha composicion en donde el componente probiotico comprende bacterias del grupo formado por Bacillus, Bacteroides, Bifidobacterium, Enterococcus, Lactobacillus, y Leuconostoc, y combinaciones de éstos, y en donde el edulcorante se selecciona del grupo gormado por monosacáridos, disacáridos, y mezclas de éstos. Dicha composicion que comprende de 0,001% a 10% de la bacteria y 50% a 99% de sorbitol, en peso de la composicion. Uso de dicha composicion para mejorar la salud de un mamífero.
ARP060101416A 2005-04-11 2006-04-10 Composiciones que comprenden componentes probioticos y edulcorantes AR052744A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67012505P 2005-04-11 2005-04-11
US11/384,050 US20100233312A9 (en) 2005-04-11 2006-03-17 Compositions comprising probiotic and sweetener components

Publications (1)

Publication Number Publication Date
AR052744A1 true AR052744A1 (es) 2007-03-28

Family

ID=36992608

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101416A AR052744A1 (es) 2005-04-11 2006-04-10 Composiciones que comprenden componentes probioticos y edulcorantes

Country Status (8)

Country Link
US (1) US20100233312A9 (es)
EP (1) EP1868624A2 (es)
JP (1) JP2008535520A (es)
AR (1) AR052744A1 (es)
AU (1) AU2006235038B2 (es)
BR (1) BRPI0609456A2 (es)
CA (2) CA2604835C (es)
WO (1) WO2006110406A2 (es)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192733B2 (en) * 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP1880001B1 (en) 2005-05-31 2011-06-08 The Iams Company Feline probiotic lactobacilli
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
WO2007126990A2 (en) * 2006-03-29 2007-11-08 Nestec S.A. Dietary supplements containing probiotics
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
FR2915388B1 (fr) * 2007-04-27 2010-12-24 Oreal Film hydrosoluble cosmetique
US20110014167A1 (en) * 2007-07-06 2011-01-20 N.V. Nutricia Use of probiotics and fibers for diarrhoea
CN101903032A (zh) * 2007-10-26 2010-12-01 布伦达·E.·穆尔 益生菌组合物及用来引起和维持体重减轻的方法
US8071150B2 (en) * 2007-12-21 2011-12-06 Frito-Lay North America, Inc. Processing technique to thaw partially frozen fruits and vegetables and incorporating solids
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
AU2010209436A1 (en) * 2009-01-27 2011-08-18 Probiotical S.P.A. Chocolate flavoured probiotic supplement
IT1393415B1 (it) * 2009-01-27 2012-04-20 Probiotical Spa Integratore probiotico al gusto di cioccolato
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US9173423B2 (en) * 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US20110027420A1 (en) * 2009-07-31 2011-02-03 Haile Mehansho Moisture migration reduction layer for a food product
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
US20110081320A1 (en) * 2009-10-06 2011-04-07 Nubiome, Inc. Treatment/Cure of Autoimmune Disease
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
US9452189B2 (en) * 2010-10-07 2016-09-27 California Institute Of Technology Probiotic therapies for autism
FR2968004B1 (fr) * 2010-11-29 2013-06-28 Sojasun Technologies Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines.
AU2011345226B2 (en) 2010-12-23 2014-11-13 Hill's Pet Nutrition, Inc. Pet food compositions and methods for treating arthritis and inflammation associated with arthritis
EP2654453B1 (en) 2010-12-23 2016-06-01 Hill's Pet Nutrition, Inc. Pet food compositions and methods for weight loss and maintenance
ES2712562T3 (es) 2011-01-14 2019-05-13 Iams Europe B V Composiciones relacionadas con los carotenoides
RU2631597C2 (ru) 2011-07-15 2017-09-25 Нусерт Сайенсиз, Инк. Композиции и способы модулирования метаболических путей
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US20130122154A1 (en) * 2011-11-14 2013-05-16 The Procter & Gamble Company Palatable Pet Foods and Methods for Improving the Palatability of Pet Foods
AU2011383737B2 (en) * 2011-12-19 2015-02-05 Hill's Pet Nutrition, Inc. Highly digestible pet food for improving stool quality
US9585925B1 (en) * 2012-05-04 2017-03-07 Vetnique Labs LLC Pet food supplement
CA2881656C (en) 2012-08-29 2023-07-11 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
JP6469015B2 (ja) 2012-11-13 2019-02-13 ニューサート サイエンシーズ， インコーポレイテッド エネルギー代謝を増大させるための組成物および方法
WO2014149280A1 (en) * 2013-03-15 2014-09-25 Nusirt Sciences, Inc. Treatment of pets with sirtuin activators
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
WO2016069795A2 (en) 2014-10-30 2016-05-06 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
KR102511878B1 (ko) 2014-10-30 2023-03-20 캘리포니아 인스티튜트 오브 테크놀로지 신경발달 장애에서의 행동을 개선하기 위한 박테리아를 포함하는 조성물 및 방법
SI3193901T1 (en) 2014-12-23 2018-06-29 4D Pharma Research Limited Pirin polypeptide and immune modulation
EP3395351A1 (en) 2014-12-23 2018-10-31 4D Pharma Research Limited Immune modulation
JP6712603B2 (ja) 2015-02-16 2020-06-24 マース インコーポレーテッドＭａｒｓ Ｉｎｃｏｒｐｏｒａｔｅｄ かみ合うキブル
MX2017013715A (es) 2015-04-28 2018-03-02 Mars Inc Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado.
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
KR20180012846A (ko) 2015-06-15 2018-02-06 4디 파마 리서치 리미티드 박테리아 균주를 함유한 조성물
MX2017016529A (es) 2015-06-15 2018-03-12 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas.
LT3206700T (lt) 2015-06-15 2019-08-26 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
LT3209310T (lt) 2015-11-20 2018-04-25 4D Pharma Research Limited Kompozicijos, apimančios bakterinius kamienus
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017116449A1 (en) * 2015-12-30 2017-07-06 Hill's Pet Nutrition, Inc. Pet food compositions
SG10201913557TA (en) 2016-03-04 2020-02-27 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
EP3465212A4 (en) 2016-05-23 2020-01-08 California Institute of Technology REGULAR FLORAL REGULATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
USD805728S1 (en) 2016-09-06 2017-12-26 Mars, Incorporated Food product
USD806351S1 (en) 2016-09-06 2018-01-02 Mars, Incorporated Food product
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
GB201701417D0 (en) 2017-01-27 2017-03-15 Mars Inc Pet food
WO2018213204A1 (en) 2017-05-15 2018-11-22 Axial Biotherapeutics, Inc. Inhibitors of microbially induced amyloid
EP3630136B1 (en) 2017-05-22 2021-04-21 4D Pharma Research Limited Compositions comprising bacterial strains
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
CN111032061A (zh) 2017-06-14 2020-04-17 4D制药研究有限公司 包含细菌菌株的组合物
TW201919670A (zh) 2017-06-14 2019-06-01 英商4D製藥研究有限公司 包含細菌品系之組成物
US20230256002A1 (en) * 2022-02-11 2023-08-17 Keith Allen Garleb Hard lozenge made with dietary fiber

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055676A (en) * 1975-05-20 1977-10-25 The Quaker Oats Company Replacement of sugar in a sugar-containing food and process
US4565702A (en) * 1984-06-04 1986-01-21 Warner-Lambert Company Dietary fiber food products and method of manufacture
ES2074515T3 (es) * 1990-11-26 1995-09-16 Nestle Sa Procedimiento y dispositivo para la fabricacion de productos alimenticios por coccion coextrusion.
JPH08126473A (ja) * 1994-09-08 1996-05-21 Fuji Oil Co Ltd 油性組成物およびその製法並びにそれを用いた油性被覆菓子
ES2164299T5 (es) * 1997-01-09 2009-03-01 Societe Des Produits Nestle S.A. Producto cereal que contiene probioticos.
US6133323A (en) * 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
EP0931543B1 (de) * 1997-12-19 2002-03-20 MERCK PATENT GmbH Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6451344B1 (en) * 1998-04-30 2002-09-17 Morinaga Milk Industry Co., Ltd. Sugar coated tablets
US20040161422A1 (en) * 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
TR200103241T2 (tr) * 1999-05-12 2002-04-22 Hercules Incorporated Yüksek katı içerikli gıda bileşimi
US6310090B1 (en) * 1999-05-27 2001-10-30 The Iams Company Process and product for enhancing immune response in companion animals using a combination of antioxidants
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
JP2001321094A (ja) * 2000-05-12 2001-11-20 Kenji Tokunaga 乳酸菌を含むローヤルゼリー錠剤の製造方法
HU230800B1 (hu) * 2000-05-25 2018-06-28 Societe des Produits Nestlé S.A Új probiotikumok hobbiállat-eledel kompozíciókhoz
GB0027761D0 (en) * 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
AU2002339112B2 (en) * 2001-11-12 2007-10-11 Mars, Incorporated Foodstuff
US20050008735A1 (en) * 2002-02-11 2005-01-13 Pearce Tony M. Chocolate polymer snacks
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
ITBO20020564A1 (it) * 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
ITMI20022343A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Pellicola a rapida dissoluzione in acqua, contenente sistanze cosmetiche, aromatiche, farmaceutiche o alimentari.
US20040202698A1 (en) * 2003-04-02 2004-10-14 The Procter & Gamble Company Drug delivery systems comprising an encapsulated active ingredient
US20050136095A1 (en) * 2003-12-22 2005-06-23 Brian Levy Drug delivery device with suture ring
WO2006007470A1 (en) * 2004-07-01 2006-01-19 General Mills, Inc. Cultures encapsulated with chocolate food products coated with chocolate and methods of preparation
US20060228448A1 (en) * 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components

Also Published As

Publication number Publication date
CA2875889A1 (en) 2006-10-19
AU2006235038B2 (en) 2011-05-19
WO2006110406A2 (en) 2006-10-19
CA2875889C (en) 2018-04-24
US20100233312A9 (en) 2010-09-16
JP2008535520A (ja) 2008-09-04
EP1868624A2 (en) 2007-12-26
WO2006110406A3 (en) 2007-07-12
BRPI0609456A2 (pt) 2010-04-06
CA2604835A1 (en) 2006-10-19
US20070218164A1 (en) 2007-09-20
AU2006235038A1 (en) 2006-10-19
CA2604835C (en) 2014-12-30

Similar Documents

Publication Publication Date Title
AR052744A1 (es) Composiciones que comprenden componentes probioticos y edulcorantes
AR066878A1 (es) Composiciones cosmeticas con resistencia a la transferencia mejorada
CR20150097A (es) Composición inmunogénica
BRPI0922924A2 (pt) composições para melhoria da saúde oral, método de uso de uma composição e uso de pelo menos uma bactéria benéfica para a preparação de uma composição para melhoria da saúde oral
DOP2012000150A (es) Triazolopiridinas
HN2005000795A (es) Pirimidinas como antagonistas del receptor de prostaglandina d2
CL2012000869A1 (es) Composicion que comprende cepa seleccionada de lactobacillus plantarum cect 7527, o cepas mutantes de la misma; uso de una composicion para prevenir y/o tratar transtornos cardiovasculares.
BRPI0921002A8 (pt) Composições para tratamento bucal compreendendo sílica fundida e seu uso
RS51185B (sr) Kompozicije za vaginalnu primenu
CL2011001940A1 (es) Uso de lactobacillus rhamnosus cncm i-4007 y una formulacion de prebioticos que comprende oligofructosa e inulina para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales.
AR058648A1 (es) Sistema abrasivo para composiciones de cuidado oral
ATE528012T1 (de) Uronsäure und probiotika
CO6290630A2 (es) Composición oral que contiene amino ácidos y particulas pequeñas
AR054936A1 (es) Goma de mascar con pegajosidad reducida
CL2008001157A1 (es) Compuestos derivados de quinolina-carboxamida, antagonistas de p2y12; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; composicion de una combinacion de dichos compuestos; y uso del compuesto en el tratamiento de trastornos cardiovasculares, tromboembolismo, infarto agudo al miocardio.
CL2009001560A1 (es) Composición nutricional para bebes que comprende una mezcla de oligosacáridos compuesta de oligosacáridos n-acetilados, galactooligosácaridos y oligosacáridos sialilados; y su uso.
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
CL2008001855A1 (es) Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa.
CL2008003016A1 (es) Composicion para tratamiento de lavanderia que comprende una base de tratamiento de lavanderia y desde 0,01 a 10% en peso de particulas de film laminar concavas coloreadas.
SG10201901259RA (en) Prebiotic formulations and methods of use
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
ATE537707T1 (de) Lactobacillus paracasei und gewichtskontrolle
IN2012DN01638A (es)
SG165315A1 (en) Alpha2c adrenoreceptor agonists

Legal Events

Date Code Title Description
FG Grant, registration